Acadia Healthcare (NASDAQ:ACHC) Cut to Sell at StockNews.com

StockNews.com cut shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a report released on Friday morning.

A number of other brokerages have also recently issued reports on ACHC. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. KeyCorp initiated coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a report on Monday, November 18th. Deutsche Bank Aktiengesellschaft increased their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, Barclays reduced their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a research report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $79.67.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $38.23 on Friday. The stock has a 50 day simple moving average of $54.15 and a 200 day simple moving average of $64.54. The stock has a market cap of $3.55 billion, a P/E ratio of 12.53, a PEG ratio of 1.71 and a beta of 1.33. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period last year, the firm earned $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

Several large investors have recently bought and sold shares of the company. Point72 Asset Management L.P. boosted its stake in Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares during the last quarter. Millennium Management LLC increased its position in Acadia Healthcare by 3,067.8% during the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock valued at $73,640,000 after buying an additional 1,055,894 shares in the last quarter. Holocene Advisors LP raised its stake in Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company’s stock valued at $61,667,000 after buying an additional 649,997 shares during the last quarter. Finally, William Blair Investment Management LLC boosted its holdings in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.